Abstract:Complex changes in the brain microenvironment following traumatic brain injury (TBI) can cause neurological impairments for which there are few efficacious therapeutic interventions. The reactivity of astrocytes is one of the keys to microenvironmental changes, such as neuroinflammation, but its role and the molecular mechanisms that underpin it remain unclear. Male C57BL/6J mice were subjected to the controlled cortical impact (CCI) to develop a TBI model. The specific ligand of AXL receptor tyrosine kinase (AXL), recombinant mouse growth arrest-specific 6 (rmGas6) was intracerebroventricularly administered, and selective AXL antagonist R428 was intraperitoneally applied at 30 min post-modeling separately. Post-TBI assessments included neurobehavioral assessments, transmission electron microscopy, immunohistochemistry, and western blotting. Real-time polymerase chain reaction (RT-PCR), siRNA transfection, and flow cytometry were performed for mechanism assessments in primary cultured astrocytes. AXL is upregulated mainly in astrocytes after TBI and promotes astrocytes switching to a phenotype that exhibits the capability of ingesting degenerated neurons or debris. As a result, this astrocytic transformation promotes the limitation of neuroinflammation and recovery of neurological dysfunction. Pharmacological inhibition of AXL in astrocytes significantly decreased astrocytic phagocytosis both in vivo and in primary astrocyte cultures, in contrast to the effect of treatment with the rmGas6. AXL activates the signal transducer and activator of the transcription 1 (STAT1) pathway thereby further upregulating ATP-binding cassette transporter 1 (ABCA1). Moreover, the supernatant from GAS6-depleted BV2 cells induced limited enhancement of astrocytic phagocytosis in vitro. Our work establishes the role of AXL in the transformation of astrocytes to a phagocytic phenotype via the AXL/STAT1/ABCA1 pathway which contributes to the separation of healthy brain tissue from injury-induced cell debris, further ameliorating neuroinflammation and neurological impairments after TBI. Collectively, our findings provide a potential therapeutic target for TBI.

Traumatic scratch injury in astrocytes triggers calcium influx to activate the JNK/c-Jun/AP-1 pathway and switch on GFAP expression.

CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions

A Pvr–AP-1–Mmp1 signaling pathway is activated in astrocytes upon traumatic brain injury

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

Live Imaging of Astrocyte Responses to Acute Injury Reveals Selective Juxtavascular Proliferation

Gfap Expression in Injured Astrocytes in Rats

Matrix stiffness changes affect astrocyte phenotype in an in vitro injury model

The absence of Nrf2 enhances NF-κB-dependent inflammation following scratch injury in mouse primary cultured astrocytes.

Astrocyte Contributes to Pain Development Via MMP2-JNK1/2 Signaling in a Mouse Model of Complex Regional Pain Syndrome.

Spatiotemporally selective ATP events from astrocytes encode injury information and guide sustained microglial response

Insight into Astrocyte Activation after Optic Nerve Injury

In vitro beneficial activation of microglial cells by mechanically-injured astrocytes enhances the synthesis and secretion of BDNF through p38MAPK.

Spatiotemporally selective astrocytic ATP dynamics encode injury information sensed by microglia following brain injury in mice

Reactive Astrocytes Increase Expression of Prongf in the Mouse Model of Contused Spinal Cord Injury.

Activation of epidermal growth factor receptors in astrocytes: from development to neural injury.

Astrocytic c-Jun N-terminal kinase-histone deacetylase-2 cascade contributes to glutamate transporter-1 decrease and mechanical allodynia following peripheral nerve injury in rats

KCa3.1 Inhibition Switches the Astrocyte Phenotype During Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways

Astrocyte-derived exosome-transported GJA1-20k attenuates traumatic brain injury in rats

Astroglial Glutamate-Glutamine Cycle is Involved in the Modulation of Inflammatory Nociception in Rats

Conditional ablation of reactive astrocytes to dissect their roles in spinal cord injury and repair

Epidermal Growth Factor Receptor Activation: an Upstream Signal for Transition of Quiescent Astrocytes into Reactive Astrocytes after Neural Injury